Industry
Biotechnology
Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Newsdesk
August 19, 2024 | 1:06 pm
Portfolio Pulse from Benzinga Newsdesk
August 19, 2024 | 1:03 pm
Portfolio Pulse from Benzinga Newsdesk
August 19, 2024 | 1:02 pm
Portfolio Pulse from Benzinga Newsdesk
July 08, 2024 | 11:34 am
Portfolio Pulse from Benzinga Newsdesk
July 08, 2024 | 10:35 am
Portfolio Pulse from Benzinga Insights
June 20, 2024 | 8:31 pm
Portfolio Pulse from Avi Kapoor
June 17, 2024 | 12:43 pm
Portfolio Pulse from Benzinga Insights
June 17, 2024 | 12:07 pm
Portfolio Pulse from Benzinga Insights
June 14, 2024 | 8:31 pm
Portfolio Pulse from Benzinga Insights
June 06, 2024 | 4:31 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.